natgillin/translations-raw huggingface dataset:
Serious infections occurred in 6.3% of rheumatoid arthritis patients treated with etanercept for up to 48 months.
Resne okužbe so se pojavile pri 6,3 % bolnikov z revmatoidnim artritisom, ki so prejemali etanercept do 48 mesecev.
Pharmacotherapeutic group: Immunosuppressants, tumour necrosis factor alpha (TNF-α) inhibitors, ATC code: L04AB01
Farmakoterapevtska skupina: Zdravila za zaviranje imunske odzivnosti, zaviralci tumorje nekrotizirajočega faktorja alfa (TNF-α), oznaka ATC: L04AB01
196 n = 46 n =
n = 196 n = 46 n = 96 n = 90
Treatment with Benepali should continue until remission is achieved, for up to 24 weeks.
Zdravljenje z zdravilom Benepali je treba nadaljevati, dokler ne dosežemo remisije, vendar največ 24 tednov.
Hypoglycaemia in patients treated for diabetes
Hipoglikemija pri bolnikih, ki se zdravijo zaradi sladkorne bolezni
If you have used more Benepali than you should (either by injecting too much on a single occasion or by using it too frequently), talk to a doctor or pharmacist immediately.
Če ste uporabili večji odmerek zdravila Benepali, kot bi smeli Če ste uporabili večji odmerek zdravila Benepali, kot bi smeli (bodisi ste ga naenkrat injicirali preveč bodisi prepogosto), se nemudoma posvetujte z zdravnikom ali farmacevtom.
Clinical responses were expressed as percentages of patients achieving the ACR 20, 50, and 70 response and percentages with improvement in Psoriatic Arthritis Response Criteria (PsARC).
Klinični odzivi so bili izraženi v odstotkih bolnikov, ki so dosegli odziv ACR 20, 50 in 70 in v odstotkih bolnikov z izboljšanjem ocene po kriterijih PsARC (Psoriatic Arthritis Response Criteria).
• Alcohol abuse: Benepali should not be used for the treatment of hepatitis related to alcohol abuse.
• Zloraba alkohola: Zdravila Benepali ne smete uporabljati za zdravljenje hepatitisa, povezanega z zlorabo alkohola.
Doctor's name:
Zdravnikovo ime:
See ‘Choose an injection site' for guidance with choosing an injection site.
Glejte "Izbira mesta injiciranja" za navodila o izbiri mesta injiciranja.
System Organ
Organski sistem
Paediatric patients who require a dose other than a full 25 mg or 50 mg should not receive Benepali.
Pediatrični bolniki, ki potrebujejo odmerek, drugačen kot polnih 25 mg ali 50 mg, zdravila Benepali ne smejo prejeti.
During the first 12 weeks of the double-blind treatment period, patients received placebo or one of the above three etanercept doses.
V prvih 12 tednih dvojno slepega obdobja zdravljenja so bolniki dobivali placebo ali enega od navedenih odmerkov etanercepta.
Within the System Organ Class, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare
Znotraj organskih sistemov so neželeni učinki navedeni po pogostnosti (število bolnikov, pri katerih se pričakuje pojav učinka), z uporabo naslednjih kategorij: zelo pogosti (≥1/10); pogosti (≥1/100 do <1/10); občasni (≥1/1.000 do <1/100); redki (≥1/10.000 do <1/1.000); zelo redki (<1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov).
• Teaching guide to facilitate training of the patients in the safe use of the pre-filled pen/prefilled syringes
• Učni vodnik, s pomočjo katerega bo bolnikom lažje razložiti varno uporabo napolnjenega injekcijskega peresnika/napolnjenih injekcijskih brizg
Although not conclusive, data from one of these trials suggest a possible tendency toward worsening CHF in those patients assigned to etanercept treatment.
Izsledki sicer še niso dokončni, vendar podatki iz enega od teh preskušanj kažejo na morebitno tendenco k poslabšanju KSP pri bolnikih, zdravljenih z etanerceptom.
It is recommended that paediatric patients, if possible, be brought up to date with all immunisations in agreement with current immunisation guidelines prior to initiating etanercept therapy (see Vaccinations, above).
Za pediatrične bolnike priporočamo, da pred začetkom zdravljenja z etanerceptom, če je le mogoče, opravijo vsa cepljenja v skladu z veljavnimi smernicami za cepljenje (glejte Cepljenja zgoraj).
Choose an injection site:
Izberite mesto injiciranja:
For patients with multiple symmetrical painful or swollen joints (e.g., hands, wrists and feet), Benepali can slow down the structural damage to those joints caused by the disease.
Pri bolnikih z več simetrično prizadetimi bolečimi ali oteklimi sklepi (npr. dlanmi, zapestji ali stopali) lahko zdravilo Benepali upočasni razvoj strukturnih okvar teh sklepov, ki jih povzroča bolezen.
Other etanercept products with appropriate dosage forms for children are available.
Na voljo so druga zdravila etanercepta z odmerki, primernimi za otroke.
This section presents data from four randomised controlled trials in adults with rheumatoid arthritis, one study in adults with psoriatic arthritis, one study in adults with ankylosing spondylitis, one study in adults with non-radiographic axial spondyloarthritis, four studies in adults with plaque psoriasis, three studies in juvenile idiopathic arthritis and one study in paediatric patients with plaque psoriasis.
V tem poglavju so prikazani podatki iz štirih randomiziranih nadzorovanih preskušanj pri odraslih z revmatoidnim artritisom, ene študije pri odraslih s psoriatičnim artritisom, ene študije pri odraslih z ankilozirajočim spondilitisom, ene študije pri odraslih z radiografsko nezaznavnim aksialnim spondilartritisom, štirih študij pri odraslih s psoriazo v plakih, treh študij pri bolnikih z juvenilnim idiopatskim artritisom in ene študije pri pediatričnih bolnikih s psoriazo v plakih.
The impact of long-term treatment with etanercept on the development of autoimmune diseases is unknown.
Vpliv dolgotrajnega zdravljenja z etanerceptom na razvoj avtoimunskih bolezni ni znan.
If inactive (‘latent') tuberculosis is diagnosed, treatment for latent tuberculosis must be started with anti-tuberculosis therapy before the initiation of Benepali, and in accordance with local recommendations.
Če se ugotovi neaktivna ('latentna') tuberkuloza, je treba pred uvedbo zdravila Benepali in v skladu z nacionalnimi priporočili začeti zdravljenje latentne tuberkuloze s tuberkulostatiki.
• Tuberculosis: As cases of tuberculosis have been reported in patients treated with Benepali, your doctor will check for signs and symptoms of tuberculosis before starting Benepali.
• Tuberkuloza: Ker so pri bolnikih, ki so se zdravili z zdravilom Benepali, poročali o primerih tuberkuloze, se bo vaš zdravnik prepričal, da nimate znakov ali simptomov tuberkuloze, preden se boste začeli zdraviti z zdravilom Benepali.
B. Injection steps Step 1:
B. Koraki injiciranja 1. korak:
Patients should be evaluated for infections before, during, and after treatment with Benepali, taking into consideration that the mean elimination half-life of etanercept is approximately 70 hours (range 7 to 300 hours).
Pred zdravljenjem z zdravilom Benepali, med njim in po njem je treba bolnike pregledati glede okužb in pri tem upoštevati, da je povprečni razpolovni čas izločanja etanercepta iz telesa približno 70 ur (razpon 7 do 300 ur).
You should consult your doctor if you become pregnant, think you may be pregnant, or are planning to have a baby.
Če zanosite, menite, da bi lahko bili noseči, ali načrtujete zanositev, se posvetujte z zdravnikom.
Patients who “failed to respond to” in the target population is defined by insufficient response (PASI < 50 or PGA less than good), or worsening of the disease while on treatment, and who were adequately dosed for a sufficiently long duration to assess response with at least each of the three major systemic therapies as available.
Bolnike v ciljni populaciji, ki ''se niso odzvali'', opredeljuje nezadosten odziv (PASI < 50 ali PGA [PGA - Physician Global Assessment] manj kot dober) ali poslabšanje bolezni med zdravljenjem, ko je bolnik prejemal najmanj vsako od treh glavnih razpoložljivih sistemskih zdravljenj v zadostnem odmerku in dovolj časa, da je bilo mogoče oceniti odziv.
*Some patients did not provide complete data for each endpoint **ASAS=Assessments in Spondyloarthritis International Society ***Bath Ankylosing Spondylitis Disease Activity Index a: p < 0.001, b: < 0.01 and c: < 0.05, respectively between etanercept and placebo
*Nekateri bolniki niso predložili popolnih podatkov za vsak opazovani dogodek **ASAS = Mednarodno združenje za ocenjevanje spondilartritisa ***Indeks Bath za ocenjevanje aktivnosti ankilizirajočega spondilitisa a: p < 0,001, b: < 0.01 oziroma c: < 0,05 med etanerceptom in placebom
You or the child should not use Benepali with medicines that contain the active substance anakinra or abatacept.
Zdravila Benepali vi ali otrok ne smete uporabljati skupaj z zdravili, ki vsebujejo učinkovino anakinro ali abatacept.
If any of the above occurs, tell your doctor immediately, or visit the casualty department at your nearest hospital.
Če se pojavi kar koli od zgoraj navedenega, se nemudoma posvetujte z zdravnikom ali pojdite v ambulanto za nujno pomoč najbližje bolnišnice.
• If you have psoriasis, do not inject into any raised, thick, red, or scaly skin patches, or lesions.
• Če imate luskavico, ne injicirajte v privzdignjena, zadebeljena, rdeča ali luskava območja kože ali v lezije.
The disability index score was significantly improved at all timepoints in psoriatic arthritis patients treated with etanercept, relative to placebo (p < 0.001).
Rezultat indeksa invalidnosti je bil bistveno boljši v vseh časovnih točkah pri bolnikih s psoriatičnim artritisom, zdravljenih z etanerceptom, v primerjavi s placebom (p < 0,001).
2 weeks
2 tedna
Significant improvement was also observed for the ASAS partial remission and BASDAI 50.
Pomembno izboljšanje so opazili tudi pri delni remisiji ASAS in
The 10 mg etanercept dose had consistently less effect on structural damage than the 25 mg dose.
10 mg odmerek etanercepta je imel ves čas manjši učinek na strukturno poškodbo sklepov kot 25 mg odmerek.
Compared to placebo, treatment with etanercept resulted in statistically significant improvement in the ASAS 40, ASAS 20 and ASAS 5/6.
Zdravljenje z etanerceptom je v primerjavi s placebom povzročilo statistično pomembno izboljšanje ASAS 40, ASAS 20 in ASAS 5/6.
Evidence of efficacy for the once-weekly dosing regimen in this patient population has been based on data from the study in patients with ankylosing spondylitis.
Pri tej skupini bolnikov dokaz učinkovitosti režima odmerjanja enkrat na teden temelji na podatkih iz študije pri bolnikih z ankilozirajočim spondilitisom.
Abbreviation: sPGA-static Physician Global Assessment a p < 0.0001 compared with placebo
Okrajšava: sPGA-statična zdravnikova splošna ocena a p < 0,0001 v primerjavi s placebom
Another study found no increased risk of birth defects when the mother had received etanercept in pregnancy.
V drugi študiji niso ugotovili povečanega tveganja za prirojene napake, kadar je mati med nosečnostjo prejemala etanercept.
If active tuberculosis is diagnosed, Benepali therapy must not be initiated.
Če je postavljena diagnoza aktivne tuberkuloze, se zdravljenja z zdravilom Benepali ne sme uvesti.
Such symptoms may point to the existence of potentially life-threatening blood disorders, which may require discontinuation of Benepali.
Ti simptomi namreč lahko kažejo na pojav življenjsko ogrožajoče bolezni krvi, pri kateri bo zdravljenje z zdravilom Benepali morda treba prekiniti.
No data are available on the secondary transmission of infection by live vaccines in patients receiving etanercept.
Podatkov o sekundarnem prenosu okužbe z živimi cepivi pri bolnikih, ki prejemajo etanercept, ni na voljo.
The difference between etanercept alone and methotrexate alone was also significant (p < 0.05).
Pomembna je bila tudi razlika med monoterapijo z etanerceptom in monoterapijo z metotreksatom (p < 0,05).
ASAS 50 and 70 responses used the same criteria with a 50% improvement or a 70% improvement, respectively.
Odziva ASAS 50 in 70 sta bila definirana po istih kriterijih, le da je šlo za 50-% oziroma
The efficacy of etanercept versus other systemic therapies in patients with moderate to severe psoriasis (responsive to other systemic therapies) has not been evaluated in studies directly comparing etanercept with other systemic therapies.
Učinkovitosti etanercepta v primerjavi z drugimi sistemskimi zdravljenji pri bolnikih z zmerno do hudo psoriazo (ki se odziva na druga sistemska zdravljenja) niso ovrednotili s študijami, v katerih bi neposredno primerjali etanercept z drugimi sistemskimi terapijami.
Alternatively, 50 mg administered once weekly has been shown to be safe and effective (see section 5.1).
Alternativno se je pokazalo, da je varen in učinkovit odmerek 50 mg enkrat na teden (glejte poglavje 5.1).
Consequently, Benepali should not be used in patients for the treatment of alcoholic hepatitis.
Zato zdravila Benepali ne smemo uporabljati pri bolnikih za zdravljenje alkoholnega hepatitisa.
A placebo-controlled trial, in which 89 adult patients were treated with etanercept in addition to standard therapy (including cyclophosphamide or methotrexate, and glucocorticoids) for a median duration of 25 months, has not shown etanercept to be an effective treatment for Wegener's granulomatosis.
S placebom nadzorovano preskušanje, v katerem je 89 odraslih bolnikov poleg standardnega zdravljenja (vključno s ciklofosfamidom ali metotreksatom in glukokortikoidi) jemalo etanercept z medianim časom zdravljenja 25 mesecev, ni pokazalo učinkovitosti etanercepta za zdravljenje Wegenerjeve granulomatoze.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free'.
Zdravilo Benepali vsebuje natrij To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
The incidence of non-cutaneous malignancies of various types was significantly higher in patients treated with etanercept than in the control group.
Incidenca nekožnih malignih obolenj različnih tipov je bila pomembno večja pri bolnikih, zdravljenih z etanerceptom, kot pri tistih v kontrolni skupini.
Wipe the skin at the injection site with an alcohol swab.
Očistite kožo na mestu injiciranja z alkoholnim zložencem.
If any serious allergic or anaphylactic reaction occurs, Benepali therapy should be discontinued immediately and appropriate therapy initiated.
Če se pojavi kakršna koli resna alergijska ali anafilaktična reakcija, je treba zdravljenje z zdravilom Benepali takoj prekiniti in uvesti ustrezno zdravljenje.
There was some evidence to support a benefit of re-treatment with etanercept in patients initially responding to treatment.
Nekaj podatkov kaže na ugoden odziv na ponovno zdravljenje z etanerceptom pri bolnikih, ki so se prvotno odzvali na zdravljenje.
In a group of 2,711 plaque psoriasis patients treated with etanercept in double-blind and open-label studies of up to 2.5 years, 30 malignancies and 43 nonmelanoma skin cancers were reported.
V skupini 2.711 bolnikov s psoriazo v plakih, zdravljenih z etanerceptom v dvojno slepih in odprtih študijah, ki so trajale do 2,5 leta, so poročali o 30 malignomih in 43 primerih nemelanomskega kožnega raka.
The largest of these trials (n = 277) enrolled patients who were between 18 and 70 years of age and had active ankylosing spondylitis defined as visual analog scale (VAS) scores of ≥ 30 for average of duration and intensity of morning stiffness plus VAS scores of ≥ 30 for at least 2 of the following 3 parameters: patient global assessment; average of VAS values for nocturnal back pain and total back pain; average of 10 questions on the Bath Ankylosing Spondylitis Functional Index (BASFI).
Največje od teh preskušanj (n = 277) je vključevalo bolnike med 18. in 70. letom starosti z aktivnim ankilozirajočim spondilitisom, definiranim po vizualni analogni lestvici (VAS) z vrednostjo ≥ 30 za povprečno trajanje in intenzivnost jutranje okorelosti ter VAS vrednost ≥ 30 za vsaj 2 od 3 sledečih parametrov: bolnikova splošna ocena; povprečna VAS vrednost bolečine v hrbtenici ponoči in celokupne bolečine v hrbtenici; povprečje 10 vprašanj v Bath Ankylosing Spondylitis Functional Index (BASFI).
In a double-blind, placebocontrolled, randomised clinical study in adult patients with psoriatic arthritis, 184 patients also received a multivalent pneumococcal polysaccharide vaccine at week 4.
V dvojno slepi, s placebom nadzorovani randomizirani klinični študiji pri odraslih bolnikih s psoriatičnim artritisom je 184 bolnikov v 4. tednu dobilo tudi multivalentno polisaharidno cepivo proti pnevmokokom.
• Stretching the skin creates a firm surface.
• Z napenjanjem kože nastane ravna površina.
In clinical trials, no interactions have been observed when etanercept was administered with glucocorticoids, salicylates (except sulfasalazine), nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, or methotrexate.
Med kliničnimi preskušanji niso opazili nobenih interakcij med etanerceptom in glukokortikoidi, salicilati (razen sulfasalazina), nesteroidnimi protivnetnimi zdravili (NSAIDs), analgetiki ali metotreksatom.
Benepali is for subcutaneous use (see section 6.6).
Zdravilo Benepali je za subkutano uporabo (glejte poglavje 6.6).
• Infections/surgery: If you or the child develop a new infection, or are about to have any major surgery, your doctor may wish to monitor the treatment with Benepali.
• Okužbe/operacije: Če se pri vas ali otroku pojavi nova okužba ali če je predvidena kakršna koli večja operacija, bo zdravnik morda želel spremljati zdravljenje z zdravilom Benepali.
It is recommended that you record the date that Benepali is removed from the refrigerator and the date after which Benepali should be discarded (no more than 4 weeks following the removal from the refrigerator).
Priporočljivo si je zabeležiti datum odvzema zdravila Benepali iz hladilnika in datum, po katerem je treba zdravilo Benepali zavreči (do 4 tedne po odvzemu iz hladilnika).
What Benepali looks like and contents of the pack
Izgled zdravila Benepali in vsebina pakiranja
If needed, cover the injection site with a plaster.
Po potrebi na mesto injiciranja nalepite obliž.
The differences in TSS and JSN were not statistically significant between methotrexate and etanercept 25 mg.
Razlike v ocenah TSS in JSN med metotreksatom in 25 mg etanercepta niso bile statistično pomembne.
After discontinuation of etanercept, symptoms of arthritis generally returned within a month.
Po prekinitvi zdravljenja z etanerceptom so se simptomi artritisa največkrat ponovno pojavili že v enem mesecu.
ASAS partial remission
Delna remisija ASAS
You can let go of the skin that you are pinching after the needle is completely inserted.
Kožo, ki jo držite, lahko izpustite, ko je igla do konca vstavljena.
If you feel that the effect of Benepali is too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila Benepali premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
TNF-antagonists, such as etanercept, affect the immune system and their use may affect the body's defenses against infection and cancer.
Antagonisti TNF, kot je etanercept, vplivajo na imunski sistem in lahko zmanjšajo sposobnost organizma za obrambo pred okužbami in rakom.
Recapping could lead to a needle stick injury.
Ponovno natikanje pokrovčka lahko povzroči vbodno poškodbo.
Although no clinical trials have been performed evaluating etanercept therapy in patients with multiple sclerosis, clinical trials of other TNF antagonists in patients with multiple sclerosis have shown increases in disease activity.
Čeprav niso opravili kliničnih preskušanj za ovrednotenje zdravljenja z etanerceptom pri bolnikih z multiplo sklerozo, so klinična preskušanja drugih antagonistov TNF pri teh bolnikih pokazala zvečano aktivnost bolezni.
DSGAb, clear or almost clear * p ≤ 0.0001 compared with placebo a No statistical comparisons to placebo were made at week 24 in studies 2 and 4 because the original placebo group began receiving etanercept 25 mg BIW or 50 mg once weekly from week 13 to week 24. b Dermatologist Static Global Assessment.
čisto ali skoraj čisto * p ≤ 0,0001 v primerjavi s placebom a V študijah 2 in 4 po 24 tednih niso opravili statističnih primerjav s placebom, ker je skupina, ki je prvotno dobivala placebo, začela dobivati 25 mg etanercepta dvakrat na teden ali 50 mg enkrat na teden od 13. do 24. tedna b Dermatološka statična splošna ocena.
However, it cannot be excluded that the combination of etanercept with methotrexate could be associated with an increase in the rate of infections.
Vendar pa ni mogoče izključiti možnosti, da se lahko stopnja pogostnosti okužb pri zdravljenju s kombinacijo etanercepta in metotreksata poveča.
After 12 weeks of treatment, patients in the placebo group began treatment with blinded etanercept (25 mg twice a week); patients in the active treatment groups continued to week 24 on the dose to which they were originally randomised.
Po 12 tednih zdravljenja so bolniki v skupini s placebom začeli slepo zdravljenje z etanerceptom (25 mg dvakrat na teden), bolniki v skupinah z aktivnim zdravljenjem pa so do 24. tedna nadaljevali z odmerkom, na katerega so bili prvotno randomizirani.
• Feeling nervous or anxious, throbbing sensations, sudden reddening of the skin and/or a warm feeling
• občutek živčnosti ali tesnobe, utripajoč občutek, nenadna pordelost kože in/ali občutek toplote;
• Wegener's granulomatosis: Benepali is not recommended for the treatment of Wegener's granulomatosis, a rare inflammatory disease.
• Wegenerjeva granulomatoza: Zdravilo Benepali ni priporočljivo za zdravljenje redke vnetne bolezni Wegenerjeve granulomatoze.
In patients who develop HBV infection, Benepali should be stopped and effective anti-viral therapy with appropriate supportive treatment should be initiated.
Pri bolnikih, pri katerih se razvije okužba s HBV, je treba zdravljenje z zdravilom Benepali prekiniti in uvesti učinkovito protivirusno ter ustrezno podporno zdravljenje.
Of patients who demonstrated a clinical response at 90 days and entered part 2 of the study, some of the patients remaining on etanercept continued to improve from month 3 through month 7, while those who received placebo did not improve.
Od bolnikov, ki so dosegli klinični odziv do 90. dneva in se vključili v drugi del študije, se je pri nekaterih bolnikih, ki so ostali na etanerceptu, klinično stanje nadalje izboljševalo od 3. do 7. meseca zdravljenja, pri tistih, ki so v drugem delu študije prejemali placebo, pa izboljšanja ni bilo.
If you forget a dose, you should inject it as soon as you remember, unless the next scheduled dose is the next day; in which case you should skip the missed dose.
Če ste na predvideni odmerek pozabili, ga morate injicirati takoj, ko se spomnite, razen če je naslednji odmerek predviden za naslednji dan.
• Do not release pressure against the injection site before the injection is complete.
• Ne popuščajte s pritiskanjem na mesto injiciranja, dokler ni injiciranje končano.
Patients weighing less than 62.5 kg should be accurately dosed on a mg/kg basis using the powder and solvent for solution for injection presentations or powder for solution for injection presentations (see below for dosing for specific indications).
Bolnikom, ki tehtajo manj kot 62,5 kg, je treba odmerek natančno izračunati na podlagi mg/kg in uporabiti obliko praška in vehikla za raztopino za injiciranje ali praška za raztopino za injiciranje (za odmerjanje pri specifičnih indikacijah glejte nadaljevanje).
Failure of the bone marrow to produce crucial blood cells; damage to nerves, including Guillain-Barré syndrome (a serious condition which can affect breathing and damage body organs); toxic epidermal necrolysis (a life-threatening skin condition).
Prenehanje tvorbe osnovnih krvnih celic v kostnem mozgu; poškodbe živcev, vključno z Guillain-Barréjevim sindromom (resno stanje, ki lahko vpliva na dihanje ali poškoduje telesne organe); toksična epidermalna nekroliza (življenje ogrožajoča kožno stanje).
Benepali is not recommended for the treatment of Wegener's granulomatosis.
Zdravila Benepali ni priporočljivo uporabljati za zdravljenje Wegenerjeve granulomatoze.